BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 22540175)

  • 1. The anaemia of Plasmodium vivax malaria.
    Douglas NM; Anstey NM; Buffet PA; Poespoprodjo JR; Yeo TW; White NJ; Price RN
    Malar J; 2012 Apr; 11():135. PubMed ID: 22540175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria.
    Woolley SD; Marquart L; Woodford J; Chalon S; Moehrle JJ; McCarthy JS; Barber BE
    Malar J; 2021 Dec; 20(1):470. PubMed ID: 34930260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, drug resistance, and pathophysiology of
    Dayananda KK; Achur RN; Gowda DC
    J Vector Borne Dis; 2018; 55(1):1-8. PubMed ID: 29916441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
    Anstey NM; Douglas NM; Poespoprodjo JR; Price RN
    Adv Parasitol; 2012; 80():151-201. PubMed ID: 23199488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax infection: a major determinant of severe anaemia in infancy.
    Kenangalem E; Karyana M; Burdarm L; Yeung S; Simpson JA; Tjitra E; Anstey NM; Poespoprodjo JR; Price RN; Douglas NM
    Malar J; 2016 Jun; 15():321. PubMed ID: 27306221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection.
    Oyong DA; Loughland JR; SheelaNair A; Andrew D; Rivera FDL; Piera KA; William T; Grigg MJ; Barber BE; Haque A; Engwerda CR; McCarthy JS; Anstey NM; Boyle MJ
    Malar J; 2019 Sep; 18(1):312. PubMed ID: 31533836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-pathological studies of Plasmodium falciparum and Plasmodium vivax - malaria in India and Saudi Arabia.
    Khan W; Zakai HA; Umm-E-Asma
    Acta Parasitol; 2014 Jun; 59(2):206-12. PubMed ID: 24827088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and severity of
    Badugu V; Gaur BK; Maini B
    J Vector Borne Dis; 2023; 60(3):252-258. PubMed ID: 37843235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors related to poor outcome of patients with severe Plasmodium vivax infection: a systematic review, meta-analysis, and analysis of case reports.
    Kotepui M; Kotepui KU; Milanez GJ; Masangkay FR
    BMC Infect Dis; 2020 May; 20(1):363. PubMed ID: 32448216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune haemolytic anaemia associated with P. vivax malaria.
    Taneja S; Agarwal N
    Trop Doct; 2019 Jan; 49(1):54-55. PubMed ID: 30293518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-erythrocyte antibodies may contribute to anaemia in Plasmodium vivax malaria by decreasing red blood cell deformability and increasing erythrophagocytosis.
    Mourão LC; Roma PM; Sultane Aboobacar Jda S; Medeiros CM; de Almeida ZB; Fontes CJ; Agero U; de Mesquita ON; Bemquerer MP; Braga ÉM
    Malar J; 2016 Aug; 15(1):397. PubMed ID: 27488382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased susceptibility of blood type O individuals to develop anemia in Plasmodium vivax infection.
    Resende SS; Milagres VG; Chaves DG; Fontes CJF; Carvalho LH; Sousa TN; Brito CFA
    Infect Genet Evol; 2017 Jun; 50():87-92. PubMed ID: 28274886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature.
    Lacerda MV; Mourão MP; Alexandre MA; Siqueira AM; Magalhães BM; Martinez-Espinosa FE; Filho FS; Brasil P; Ventura AM; Tada MS; Couto VS; Silva AR; Silva RS; Alecrim MG
    Malar J; 2012 Jan; 11():12. PubMed ID: 22230294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual case of Plasmodium vivax malaria monoinfection associated with crescentic glomerulonephritis: a need for vigilance.
    Patel MP; Kute VB; Gumber MR; Gera DN; Shah PR; Patel HV; Trivedi HL; Vanikar AV
    Parasitol Res; 2013 Jan; 112(1):427-30. PubMed ID: 22806325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India.
    Sharma R; Gohain S; Chandra J; Kumar V; Chopra A; Chatterjee S; Aneja S; Dutta AK
    Paediatr Int Child Health; 2012 Aug; 32(3):152-7. PubMed ID: 22824663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Plasmodium vivax malaria in pregnancy.
    Nosten F; McGready R; Simpson JA; Thwai KL; Balkan S; Cho T; Hkirijaroen L; Looareesuwan S; White NJ
    Lancet; 1999 Aug; 354(9178):546-9. PubMed ID: 10470698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Plasmodium falciparum and Plasmodium vivax malaria among adults at Kassala Hospital, eastern Sudan.
    Abdallah TM; Abdeen MT; Ahmed IS; Hamdan HZ; Magzoub M; Adam I
    Malar J; 2013 May; 12():148. PubMed ID: 23634728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium vivax malaria: is it actually benign?
    Singh H; Parakh A; Basu S; Rath B
    J Infect Public Health; 2011 Jun; 4(2):91-5. PubMed ID: 21663878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.